Over Half of Radiologists Don’t Report Gadolinium Retention
A worldwide study published in Current Problems in Diagnostic Radiology revealed that many radiologists don’t report gadolinium retention in the brain. In fact, out of all the radiologists interviewed, 58% did not include the retention in their radiology reports. This means that thousands of people could be misdiagnosed right now instead of knowing they have gadolinium retention.
Gadolinium is a chemical element carrying the atomic number 64 and the atomic symbol Gd. Belonging to a group of elements in the periodic table called Lanthanides, the chemical is a rare earth element. Many devices use this element like microwave applications, color TV tubes, synthetic gemstones, compact discs, and computer memory. Also, medical professionals use gadolinium as an injectable contrast agent when patients undergo magnetic resonance Imaging (MRI) and magnetic resonance angiography (MRA) scans. The medical community believes that when injected with this dye the body expels it naturally within a few hours. However, this is not always the case. The chemical agent can also stay in the body for months or years following a single imaging session.
Radiologist Reporting Gadolinium Retention Study
Current Problems in Diagnostic Radiology published a study with survey data from almost 100 radiologists. During the survey, 57 radiologists observed gadolinium retention in the brain during an MRI. However, 58% of the radiologists admitted that their reports did not include gadolinium toxicity in their reports. The most common reason for not reporting was that the radiologists didn’t want to risk provoking patient anxiety.
This study only showed a small number of radiologists. This means that many radiologists across the United States aren’t revealing gadolinium retention to their patients either. Without acknowledging this is a very real illness, radiologists leave thousands of others to be hurt by this dye.
Free Case Evaluation
A gadolinium lawsuit may be an option for patients suffering from gadolinium retention and related complications. Gadolinium, used in dyes to increase the clarity of MRI and MRA scans, can create chemical element retention in the body, Therefore, this increases the risk of gadolinium deposition disease and nephrogenic systemic fibrosis. These conditions are accompanied by symptoms that include severe physical pain and cognitive difficulties. Affected patients and their loved ones may be able to file a lawsuit and recover damages.
For more information, contact The Michael Brady Lynch Firm. We offer free, confidential, no-obligation consultations. We have also over 20 years experience helping consumers injured by unsafe products manufactured by large companies.